BioWorld

Aug. 27, 2002

View Archived Issues

Alkermes Trims Staff By 23% After Risperdal Consta Delay

The fallout continues at Alkermes Inc., which following a series of recent setbacks reported a 23 percent reduction in its work force. (BioWorld Today) Read More

Bush Insider McClellan Appears To Head FDA Commissioner List

Read More

Herpes Infects Mouse Virus To Take On Complement Killers In Acute, Chronic, Latent Infection

Read More

Uncertainties Around Finances, Elan Lead Incara To Stop Trial

Read More

Other News To Note

Read More